Strong surrogate-first thesis with a structural lemons-problem moat; performance constrained by an unmeasured pipeline past Typeform, single-vendor lead concentration, and zero conversion events recorded in Google Analytics despite five configured.
90-second strategic read for Peter and Samara: data foundation first, methodology second, the numbers third.
The thesis is sound; the measurement layer is not. BornVia is the only surrogate-first referral marketplace in the market — Nodal occupies the IP-side, traditional agencies own both sides. The strategic moat (Akerlof's lemons problem applied to surrogacy) is real. The operational pull-through is fragile: $37K/mo deployed against a single vendor, zero conversion events recorded in Google Analytics despite 5 configured, and no validated drop-off rate between Typeform completion, portal onboarding, screening start, and match. The trial converts on measuring every funnel stage before the first paid-channel scale-up — not on launching ads into a black box.
A. The pipeline funnel and its primary growth constraint. B. Channel imbalance and dependency risk. C. Messaging vs. category-winning patterns.
| Channel | Spend % | Stated CPL | Cost / Match-Ready | Verdict |
|---|---|---|---|---|
| JSA Vendor | 100% | $231 M | N/A — 0 matches | Concentration risk |
| Google Ads (paid search) | 0% | N/A — not live | N/A | Gated by healthcare cert |
| Meta Ads (paid social) | 0% | N/A — not live | N/A | Gated by compliance layer |
| Organic Search / SEO | $0 (staff time) | ~$0 marginal | N/A | Latent — 4 blogs ranking |
| Organic Social (IG) | $0 | ~$0 marginal | N/A | Account exists, no strategy |
| Word-of-Mouth / Referral | $0 | ~$0 | N/A | Dormant — needs first matches |
Demand cycles, supply constraint, structural shifts, buying triggers. Where BornVia's thesis intersects market reality.
Sorted by severity. Each card: problem state · root cause · quantified impact.
5A Positioning map · 5B Messaging patterns · 5C Acquisition strategy · 5D Where BornVia sits · 5E White space.
| Brand | Positioning | Messaging | Channel Strength | Where they win | Where BornVia wins |
|---|---|---|---|---|---|
| BornVia | Surrogate-first referral marketplace | "What surrogacy was meant to be" — brand-led | JSA only ($37K/mo) | — | Multi-agency comparison; agency-pays incentive structure |
| Nodal | IP-first tech marketplace | "Surrogacy the way it should be" + 45-day match speed | VC-backed paid + Forbes/Axios PR | 108 matches, MD founder, $8.7M funding, press | Surrogate gets compensation comparison; Nodal's surrogates see only IPs |
| Circle Surrogacy | Premium full-service agency · 30+ yrs | "99.1% success · 3,800 babies" | Clinic referrals (400) + international | Trust by track record; refund guarantee; LGBTQ+ focus | Single-agency lock-in; 96% rejection rate creates BornVia's supply pool |
| Growing Generations | Premium agency · LGBTQ+ specialist | Outcome-led; surrogate compensation transparency | SEO + clinic + international IP | Higher surrogate comp ($70–75K first-timer) | Same agency-lock-in problem; not surrogate-advocacy by structure |
| ConceiveAbilities | Mid-market full-service agency | "Bridges Program" surrogate community | Surrogate-side content + community | Strong surrogate-side content authority | Still IP-pays; surrogate is supply, not customer |
| Surrogate-First | Surrogate-advocacy positioning | Similar value-prop language as BornVia | Minimal — content/community | Earlier name recognition for "surrogate-first" | BornVia has operational capacity (Samara's 14 yrs); Surrogate-First doesn't have screening infrastructure |
| Brand | Primary Lever | Content Velocity | ICP Segmentation | Outbound Motion | SEO Authority |
|---|---|---|---|---|---|
| BornVia | JSA leads ($37K/mo) | 4 blogs total | None — surrogate generic | Samara's network (agencies) | ~74 sessions/mo organic H |
| Nodal | Paid social + PR | Steady blog + press | IP segments (LGBTQ+, intl) | Direct-to-IP digital | High — Forbes/Axios backlinks |
| Circle Surrogacy | Clinic referrals | Heavy content + international landing pages | 70-country segmentation | Field reps + clinic relationships | Very high — domain age + content depth |
| Growing Generations | SEO + clinic referrals | Strong educational hub | LGBTQ+ + age-specific | IP-side outbound | High — keyword leadership |
| ConceiveAbilities | Surrogate community + content | Multi-channel surrogate content | Surrogate-segmented (vets, military, FT mom) | Webinars + community events | High — surrogate-side query authority |
Sized by leverage and sequenced by gating dependency. Quick = Days 14–45 · Mid = Days 45–90 · Long = Days 90+.
The differentiator isn't more reporting — it's a system that converts inputs into compounding outcomes.
Strategic sequencing logic. Tactical 30-60-90 detail will follow at the Day-14 30-60-90 Plan Presentation.
Stabilize the measurement layer before scaling the spend layer. Scale owned channels before expanding products. Compound the asset base (testimonials, agency partners, organic content) before extending into adjacent verticals (egg donation).
Six triggers reviewed weekly. Each trigger has a healthy band, an action band, and an explicit owner.
| Metric | Healthy Threshold | Trigger Threshold | Action | Owner |
|---|---|---|---|---|
| CPL (any channel) | <$150 | >$280 for 2 consecutive weeks | Pause channel; investigate exclusivity / saturation | Peter |
| App completion rate (lead → Typeform submit) | >65% | <45% for 1 week | Form audit; reduce questions; A/B 2-step qualifier | Samara + Jonathan |
| Portal onboard rate (app → portal login) | >80% | <50% for 1 week | Handoff path review; SMS-first link test | Mark + Suvik |
| Screening pass rate | >70% | <55% for 4 weeks | Qualification gate review with Megan; lead-quality audit | Samara |
| Time to match (app → fee collected) | <120 days | >180 days for 50%+ of cohort | Agency network capacity review; geo coverage audit | Peter |
| Tracked conversion events (Typeform submits) | ≥ Typeform completion count | 0 events in any week | Re-deploy server-to-server tracking; audit cross-site measurement | Jonathan + MH-1 |
These thresholds are reviewed weekly and adjust to the prior 4-week trailing average — guardrails compound, not pause, the system.
Three time horizons. We'll align on the path forward at the 30-60-90 Plan Presentation (Day 14).